Flurithromycin

Flurithromycin is a macrolide antibiotic used in the treatment of various bacterial infections. It belongs to the class of macrolide antibiotics, which are known for their broad-spectrum antibacterial activity. Flurithromycin is particularly effective against Gram-positive bacteria and some Gram-negative bacteria.
Mechanism of Action[edit]
Flurithromycin works by inhibiting bacterial protein synthesis. It binds to the 50S subunit of the bacterial ribosome, thereby preventing the translocation of peptides during translation. This action effectively halts bacterial growth and replication, making it a bacteriostatic agent.
Pharmacokinetics[edit]
Flurithromycin is well-absorbed from the gastrointestinal tract and has a high bioavailability. It is metabolized in the liver and excreted primarily through the kidneys. The drug has a relatively long half-life, which allows for less frequent dosing compared to some other antibiotics.
Clinical Uses[edit]
Flurithromycin is used to treat a variety of infections, including:
- Respiratory tract infections
- Skin and soft tissue infections
- Urinary tract infections
- Gastrointestinal infections
Side Effects[edit]
Common side effects of flurithromycin include:
Less common but more serious side effects can include:
Contraindications[edit]
Flurithromycin should not be used in patients with a known hypersensitivity to macrolide antibiotics. Caution is advised in patients with pre-existing liver conditions or those taking medications that can prolong the QT interval.
Drug Interactions[edit]
Flurithromycin can interact with several other medications, including:
These interactions can lead to increased levels of the co-administered drugs, necessitating careful monitoring and possible dose adjustments.
History[edit]
Flurithromycin was developed as a derivative of erythromycin to improve its pharmacokinetic properties and reduce gastrointestinal side effects. It has been used in clinical practice since the late 20th century.
See Also[edit]
References[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
